Concepedia

Fengjiao Dunbar

FD

Statistics

Publications

4

Citations

147

H-Index

4

Active since

2020

Affiliations

AbbVie (United States)(Current)

AbbVie (Germany)

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Children's Health Queensland Hospital and Health Service

University of Duisburg-Essen

Fengjiao Dunbar is an author at AbbVie (United States) specializing in oncology, medicine, and relapsed acute lymphoblastic leukemia.

Publications per year

2020–2025

4

Publications

4

Targeting <scp>BCL</scp>‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

Jonathan L. Kaufman, Cristina Gasparetto, Fredrik Schjesvold et al. · American Journal of Hematology · 2020 · 110 citations · Full text

, , +15

Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Harboring Heterogeneous Genomic Profiles Respond to Venetoclax in Combination with Chemotherapy

Andrew E. Place, Seth E. Karol, Christopher J. Forlenza et al. · Blood · 2020 · 14 citations

, , +12

Estimating colocalization probability from limited summary statistics

Emily A. King, Fengjiao Dunbar, J. Wade Davis et al. · BMC Bioinformatics · 2021 · 13 citations · Full text

, , +15

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Andrew E. Place, Seth E. Karol, Christopher J. Forlenza et al. · Pediatric Blood & Cancer · 2025 · 10 citations

, , +17

1–4 of 4